Skip to main content
Results: 21โ€“28 working days Sample: Whole blood (EDTA tube) or dried blood spot (FTA card)

Test Price

2,800 AED

โœ… Home Collection Available

๐Ÿ“‹ Results in 21โ€“28 working days

SCNN1A Gene Pseudohypoaldosteronism Type 1 Autosomal Recessive Genetic Test in UAE | 2,800 AED | DHA Licensed

Executive Summary & Core Metrics

  • โ€ข Diagnostic Sensitivity: 99.9% achieved through ISO-compliant processing and validated NGS methodology.
  • โ€ข Premium Logistics: ISO-certified home phlebotomy with temperature-controlled cold-chain transport; VIP mobile service daily 8 AM โ€“ 11 PM.
  • โ€ข Post-Test Support: Complimentary phone consultation with a consultant medical geneticist to review results and guide next steps.
  • โ€ข Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

This next-generation sequencing (NGS) test analyses all coding exons and splice sites of the SCNN1A gene to diagnose autosomal recessive pseudohypoaldosteronism type 1 (PHA1), a rare salt-wasting disorder presenting in infancy. Conducted in our DHA-licensed Dubai Healthcare City laboratory, the assay delivers results within 21โ€“28 working days with 99.9% diagnostic sensitivity, supporting precise clinical management and family planning decisions.

Feature Our NGS Test Closest Alternative (Sanger Sequencing)
Methodology Next-Generation Sequencing (NGS) โ€“ full gene coverage Sanger sequencing โ€“ limited to selected exons
Diagnostic Sensitivity 99.9% ~95%
Turnaround Time 21โ€“28 working days 4โ€“6 weeks
Copy Number Variants Detected Not detected
Price (AED) 2,800 2,200โ€“2,500

Physician Insight & Safety Protocols

"As a clinical geneticist, I recognize the emotional weight that accompanies genetic testing for a rare, life-altering condition. The SCNN1A NGS test provides critical diagnostic clarity, yet results must always be interpreted alongside the full clinical picture and biochemical data. I strongly advise families to review findings only with a specialist who can tailor salt supplementation and fludrocortisone therapy appropriately."

โ€” Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Advisory & Clinical Guidance

  • โ€ข This test is not intended for emergency diagnosis; a suspected salt-wasting crisis requires immediate hospital admission, not genetic testing.
  • โ€ข Patients with active severe dehydration, hypotension, or cardiac arrhythmia should seek emergency care before arranging the test.
  • โ€ข Sample collection must be performed by a licensed phlebotomist using aseptic technique; hemolyzed or clotted samples will be rejected and recollection requested.
  • โ€ข The test requires informed consent and, whenever possible, a pre-test genetic counselling session to construct a pedigree.

Exclusion Criteria & Medication Safety

โš  Important: Do not discontinue prescribed medications (e.g., salt supplements, fludrocortisone) without consulting your doctor. Sudden cessation can precipitate a life-threatening salt-wasting crisis. This test is contraindicated for patients who are unable to provide a valid blood sample (e.g., severe anemia, clotting disorders) or who have undergone a recent blood transfusion (within 90 days) that may interfere with DNA analysis.

Patient FAQ & Clinical Guidance

1. What is the SCNN1A genetic test, and who needs it?

This genetic test detects mutations in the SCNN1A gene linked to pseudohypoaldosteronism type 1 for patients with salt-wasting symptoms. It is indicated for infants and children presenting with hyponatremia, hyperkalemia, and metabolic acidosis, as well as for carrier screening in families with a known mutation. The assay analyses all coding exons and adjacent intronic regions, providing a comprehensive molecular diagnosis that guides personalized salt supplementation and fludrocortisone therapy.

2. How is the sample collected, and is home collection available?

We provide ISO-certified home blood collection by a licensed phlebotomist, with samples transported under strict cold-chain conditions. A small volume of whole blood (3โ€“5 mL in EDTA tube) or a dried blood spot on an FTA card is acceptable. Our VIP mobile phlebotomy service operates daily from 8 AM to 11 PM across all Emirates. Once collected, the sample is couriered to our central laboratory in temperature-controlled packaging, preserving DNA integrity and ensuring reliable sequencing results.

3. What does a positive or negative result mean for my health?

A positive result confirms autosomal recessive PHA1, guiding salt supplementation and fludrocortisone therapy, while a negative result reduces likelihood but does not absolutely exclude the condition. Homozygous or compound heterozygous pathogenic variants confirm the diagnosis and mandate lifelong management. A negative report does not exclude deep intronic or copy-number variants; clinical correlation remains essential. Genetic counselling is recommended after every result to explain inheritance risks and reproductive options.

UAE Regulatory & Data Privacy Adherence

This genetic test is performed in full compliance with the United Arab Emirates legal framework governing medical data and patient privacy:

  • Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) โ€“ ensuring secure collection, storage, and transfer of your genetic and clinical information.
  • Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields โ€“ governing the electronic handling of health records and telemedicine interactions.
  • Federal Decree-Law No. 4 of 2016 on Medical Liability โ€“ establishing accountability for clinical procedures and requiring informed consent before any diagnostic intervention.

Your sample and data are processed under strict confidentiality protocols. For any privacy-related concerns, contact our Data Protection Officer at dpo@dnalabsuae.com.

Clinical & Logistical Metadata

Test Name SCNN1A Gene Sequencing (NGS) โ€“ Pseudohypoaldosteronism Type 1
Price (AED) 2,800
Turnaround Time 21โ€“28 working days
Sample Type / Matrix Whole blood (EDTA tube) or dried blood spot (FTA card)
Methodology Used Next-Generation Sequencing (NGS) โ€“ full coding exon and splice site analysis
ICD-10-CM Code E27.40
LOINC Code 83275-3
DHA Facility License & Laboratory Address License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ€“ DNA Labs UAE

ุฏุนู… ุซู†ุงุฆูŠ ุงู„ู„ุบุฉ ู…ุชุงุญ

ุงู„ุชุญู‚ู‚ ู…ู† ุงู„ุชุบุทูŠุฉ ุงู„ุชุฃู…ูŠู†ูŠุฉ

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

ุชูˆู‚ู ุนู† ุงู„ุชุฎู…ูŠู†. ุฃุฑุณู„ ุตูˆุฑุฉ ู…ู† ุจุทุงู‚ุฉ ุงู„ุชุฃู…ูŠู† ูˆูˆุตูุฉ ุงู„ุทุจูŠุจ ุฅู„ู‰ ูุฑูŠู‚ ุงู„ุชุญู‚ู‚ ุงู„ู…ุนุชู…ุฏ ู…ู† ู‡ูŠุฆุฉ ุงู„ุตุญุฉ ุจุฏุจูŠ ุนุจุฑ ุงู„ูˆุงุชุณุงุจ. ุงุญุตู„ ุนู„ู‰ ุชุญุฏูŠุซ ุงู„ุญุงู„ุฉ ููŠ ุฏู‚ุงุฆู‚.

โœ… DHA Certified โœ… ISO 15189 โœ… HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

Preparation Required

["Informed consent required", "Pre-test genetic counselling recommended"]

Medically Reviewed by Dr. Lina Osama Zaki Quteineh

All content reviewed by qualified professionals for accuracy.

๐Ÿ…

ISMS 27001:2022

๐Ÿ“‹

ISO Accredited

๐Ÿ”’

HIPAA

All reports reviewed by DHA-Certified physicians